These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10905133)

  • 1. [Interventional or conservative approaches in acute coronary syndromes].
    Rapezzi C; Ortolani P; Branzi A
    Ital Heart J; 2000 Jun; 1 Suppl 2():78-82. PubMed ID: 10905133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III.
    Cohen M; Diez JE; Levine GN; Ferguson JJ; Morrow DA; Rao SV; Zidar JP; ;
    J Invasive Cardiol; 2007 Dec; 19(12):525-38; quiz 539-40. PubMed ID: 18180524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regarding antithrombotic treatment after coronary stenting in patients on chronic oral anticoagulation.
    Rubboli A; Colletta M; Di Pasquale G
    Am Heart J; 2005 Feb; 149(2):E1. PubMed ID: 15846242
    [No Abstract]   [Full Text] [Related]  

  • 4. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE).
    Budaj A; Brieger D; Steg PG; Goodman SG; Dabbous OH; Fox KA; Avezum A; Cannon CP; Mazurek T; Flather MD; Van De Werf F;
    Am Heart J; 2003 Dec; 146(6):999-1006. PubMed ID: 14660991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association.
    Lansky AJ; Hochman JS; Ward PA; Mintz GS; Fabunmi R; Berger PB; New G; Grines CL; Pietras CG; Kern MJ; Ferrell M; Leon MB; Mehran R; White C; Mieres JH; Moses JW; Stone GW; Jacobs AK; ;
    Circulation; 2005 Feb; 111(7):940-53. PubMed ID: 15687113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic therapy for percutaneous coronary intervention.
    Barman N; Bhatt DL
    Cardiol Clin; 2006 May; 24(2):175-99, v-vi. PubMed ID: 16781937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet agents in acute coronary syndromes.
    Eikelboom JW; Anand S
    Semin Vasc Med; 2003 Nov; 3(4):403-14. PubMed ID: 15199447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
    Bryniarski L; Pelc-Nowicka A; Zabojszcz M; Mirek-Bryniarska E
    Cardiol J; 2009; 16(2):179-89. PubMed ID: 19387970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive thrombolytic agents with coronary interventional techniques.
    Yakubov SJ; George BS; Chapekis AT
    Cardiol Clin; 1994 Nov; 12(4):573-84. PubMed ID: 7850829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current antiplatelet therapies: benefits and limitations.
    Angiolillo DJ; Guzman LA; Bass TA
    Am Heart J; 2008 Aug; 156(2 Suppl):S3-9. PubMed ID: 18657680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute myocardial infarction: thrombolysis].
    Branzi A; Ortolani P
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):711-5. PubMed ID: 12497809
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary angioplasty compared with thrombolysis: new issues in the era of glycoprotein IIb/IIIa inhibition and intracoronary stenting.
    Gibson CM
    Ann Intern Med; 1999 May; 130(10):841-7. PubMed ID: 10366375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Platelet activation in acute coronary syndrome and interventional therapy].
    Bigalke B; Lindemann S; Gawaz M
    Hamostaseologie; 2007 Dec; 27(5):338-43. PubMed ID: 18060243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glycoprotein 2b3a inhibitors for acute coronary syndromes: what the trials tell us].
    Elian D; Guetta V
    Harefuah; 2003 May; 142(5):350-4, 398. PubMed ID: 12803058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of failed thrombolysis after acute myocardial infarction: an overview of current treatment options.
    Mendoza CE; Bhatt MR; Virani S; Schob AH; Levine S; Ferreira AC; de Marchena E
    Int J Cardiol; 2007 Jan; 114(3):291-9. PubMed ID: 17079034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic, antithrombin, and antiplatelet treatment of acute coronary syndromes.
    Puma JA; Sketch MH
    J Am Osteopath Assoc; 2000 Nov; 100(11 Suppl):S8-12. PubMed ID: 11191119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.